FUNCTION II: Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Left Main Coronary Artery Stenosis

Sponsor
China National Center for Cardiovascular Diseases (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06053944
Collaborator
(none)
120
15.2

Study Details

Study Description

Brief Summary

This is a prospective, observational, single-center study. The main purpose of this study is to evaluate the diagnostic accuracy of offline computational ultrasonic flow ratio (UFR) in predicting functionally significant left main (LM) coronary stenosis with conventional pressure wire-based fractional flow reserve (FFR) as the standard reference. The study will be conducted in Fuwai Hospital, and a total of 120 patients with intermediated left main coronary vessel diameter stenosis ≥30% and ≤80% are planned to be recruited. Participants who meet the inclusion criteria and do not meet the exclusion criteria will undergo intravascular ultrasound (IVUS) followed by FFR examination. IVUS imaging will be sent to an independent core laboratory for UFR calculation. UFR analyses were performed offline in a blinded fashion without awareness of FFR measurement. Using FFR≤0.80 as the gold standard, the sensitivity and specificity of UFR in the functional significance of left main coronary artery stenosis will be analyzed.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: fractional flow reserve (FFR); ultrasonic flow ratio (UFR); intravascular ultrasound (IVUS)

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
120 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Left Main Coronary Artery Stenosis
Anticipated Study Start Date :
Sep 25, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. Diagnostic accuracy of UFR in predicting functionally significant left main coronary stenosis, using FFR as the reference standard [Immediately after the procedure]

    Diagnostic accuracy is defined as UFFR (≤0.80 or >0.80) to identify hemodynamically-significant left main coronary stenosis with FFR (≤0.80 or >0.80) as the reference standard.

  2. Sensitivity and specificity of UFR in predicting functionally significant left main coronary stenosis, using FFR as the reference standard [Immediately after the procedure]

    Sensitivity is defined as the proportion of UFR ≤ 0.80 in vessels with hemodynamically-significant stenosis as measured by FFR (FFR ≤ 0.80); specificity is defined as the proportion of UFR > 0.80 in vessels without hemodynamically-significant stenosis as measured by FFR (FFR > 0.80).

Secondary Outcome Measures

  1. Comparison of sensitivity and specificity of UFR and IVUS-derived minimal lumen area (MLA) in predicting functionally significant left main coronary stenosis, using FFR as the reference standard [Immediately after the procedure]

    Sensitivity is defined as the proportion of UFR ≤ 0.80 in vessels with hemodynamically-significant stenosis as measured by FFR (FFR ≤ 0.80); specificity is defined as the proportion of UFR > 0.80 in vessels without hemodynamically-significant stenosis as measured by FFR (FFR > 0.80).

  2. The AUC of UFR for left main coronary stenosis with FFR as the gold standard [Immediately after the procedure]

    AUC is defined as the area under the receiver-operating characteristic curve.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stable angina pectoris, unstable angina pectoris, or after the acute phase of myocardial infarction

  • Age ≥18 years

  • Written informed consent

  • Intermediated left main coronary lesions (diameter stenosis of 30%-80% by visual estimation from coronary angiography)

Exclusion Criteria:
  • Ineligible for diagnostic IVUS or FFR examination

  • Prior coronary artery bypass grafting of the interrogated vessels

  • Myocardial infarction within 72 h of coronary angiography

  • Severe heart failure

  • Serum creatinine levels >150 umol/L, or glomerular filtration rates <45 ml/ kg/1.73 m2

  • Allergy to the contrast agent or adenosine

  • Life expectancy < 2 years

  • Proximal LAD diffuse lesions (diameter stenosis > 50%)

  • IVUS pullback not covering the entire lesion

  • Severe myocardial bridge in the interrogated vessel

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • China National Center for Cardiovascular Diseases

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
China National Center for Cardiovascular Diseases
ClinicalTrials.gov Identifier:
NCT06053944
Other Study ID Numbers:
  • 2022-12M-C&T-B-043
First Posted:
Sep 26, 2023
Last Update Posted:
Sep 26, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by China National Center for Cardiovascular Diseases
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 26, 2023